Page last updated: 2024-09-02

exp3174 and ticlopidine

exp3174 has been researched along with ticlopidine in 1 studies

Compound Research Comparison

Studies
(exp3174)
Trials
(exp3174)
Recent Studies (post-2010)
(exp3174)
Studies
(ticlopidine)
Trials
(ticlopidine)
Recent Studies (post-2010) (ticlopidine)
236294310,2891,8934,671

Protein Interaction Comparison

ProteinTaxonomyexp3174 (IC50)ticlopidine (IC50)
Alpha-2A adrenergic receptorHomo sapiens (human)0.382
Cytochrome P450 2D6Homo sapiens (human)6.2928
Alpha-2B adrenergic receptorHomo sapiens (human)0.304
Alpha-2C adrenergic receptorHomo sapiens (human)1.175
Cytochrome P450 2B6Homo sapiens (human)0.405
Cytochrome P450 2C19Homo sapiens (human)0.6678
Sigma non-opioid intracellular receptor 1Homo sapiens (human)0.426

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cho, YA; Choi, JS; Yang, SH1

Other Studies

1 other study(ies) available for exp3174 and ticlopidine

ArticleYear
Effects of ticlopidine on pharmacokinetics of losartan and its main metabolite EXP-3174 in rats.
    Acta pharmacologica Sinica, 2011, Volume: 32, Issue:7

    Topics: Animals; Antihypertensive Agents; Area Under Curve; Aryl Hydrocarbon Hydroxylases; Cell Line; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Drug Interactions; Humans; Imidazoles; Inhibitory Concentration 50; Losartan; Male; Platelet Aggregation Inhibitors; Rats; Rats, Sprague-Dawley; Tetrazoles; Ticlopidine

2011